Loss of Snx10 enhances malignancy markers in pancreatic ductal adenocarcinoma (PDAC) models, suggesting a critical role in tumor progression.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Khan et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: